Septerna, Inc. (SEPN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SEPN SEC filings page.
Septerna, Inc. (SEPN) reported $98.9M in revenue over the twelve months to Jun 30, 2026, up 13520.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Septerna is still development-led: FY2025 revenue reached $46.0M , while R&D spending remained more than twice as large.
The key earnings-quality issue is FY2025’s cash reversal: operating cash flow was$110.2M even as operating loss was$68.3M , after both were negative in FY2024. With receivables rising to$10.4M , reported cash generation appears driven at least partly by non-earnings movements rather than current operating profitability.
Revenue scaled from
The balance sheet has a positive capital base: total equity was
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Septerna, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Septerna, Inc.'s reported operating margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 11/100.
Septerna, Inc.'s revenue surged 4174.5% year-over-year to $46.0M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Septerna, Inc. has a moderate D/E ratio of 0.56. This balance of debt and equity financing earns a leverage score of 58/100.
With a current ratio of 4.73, Septerna, Inc. holds $4.73 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.
Septerna, Inc.'s reported free cash flow margin for fiscal year 2025 is above the highest share of revenue this page publishes, so the figure is not shown here. This dimension scores 1/100.
Septerna, Inc. posts a -12.8% return on equity (ROE), meaning it loses $13 for every $100 of shareholders' equity. This results in a returns score of 23/100. This is up from -17.1% the prior year.
Septerna, Inc. scores 4.97, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.8B) relative to total liabilities ($214.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Septerna, Inc. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Septerna, Inc. reported a net loss of $48.9M while generating $110.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Septerna, Inc. generated $26.7M in revenue in Q2 2026. This represents an increase of 22375.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.
Septerna, Inc.'s EBITDA was -$16.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 42.5% from the same quarter a year earlier. Against the prior quarter it is down 27.4%.
Septerna, Inc. reported -$13.0M in net income in Q2 2026. This represents an increase of 47.5% from the same quarter a year earlier. Against the prior quarter it is down 50.9%.
Septerna, Inc. earned -$0.29 per diluted share (EPS) in Q2 2026. This represents an increase of 48.2% from the same quarter a year earlier. Against the prior quarter it is down 52.6%.
Cash & Balance Sheet
Septerna, Inc. recorded an outflow of $22.2M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 9.0% from the same quarter a year earlier. Against the prior quarter it is up 16.2%.
Septerna, Inc. held $84.7M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Septerna, Inc.'s operating margin was -62.9% in Q2 2026, reflecting core business profitability. Against the prior quarter it is down 12.8 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Septerna, Inc.'s net profit margin was -48.7% in Q2 2026, showing the share of revenue converted to profit. Against the prior quarter it is down 16.2 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Septerna, Inc.'s ROE was -3.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.
Not reported for Q2 2026.
Capital Allocation
Septerna, Inc. invested $35.1M in research and development in Q2 2026. This represents an increase of 58.3% from the same quarter a year earlier. Against the prior quarter it is up 19.0%.
Septerna, Inc. reported no capital expenditure in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Not reported for Q2 2026.
SEPN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.7M+22375.6% | $26.5M+12011.0% | $24.1M+11276.4% | $21.5M+12113.1% | $119K-67.8% | $219K-30.9% | $212K | $176K+433.3% |
| R&D Expenses | $35.1M+58.3% | $29.5M+53.3% | $31.9M+64.9% | $24.3M+36.1% | $22.2M+47.6% | $19.3M+46.5% | $19.3M | $17.8M+92.1% |
| SG&A Expenses | $8.4M+22.3% | $10.3M+50.0% | $8.3M+47.5% | $7.1M+45.4% | $6.9M+103.2% | $6.9M+158.4% | $5.6M | $4.9M+75.3% |
| Operating Income | -$16.8M+41.9% | -$13.3M+48.7% | -$16.0M+35.2% | $2.6M+111.6% | -$29.0M-60.4% | -$25.9M-67.3% | -$24.7M | -$22.6M-87.3% |
| EBITDA | -$16.4M+42.5% | -$12.9M+49.4% | -$15.6M+35.8% | $3.0M+113.6% | -$28.6M-60.9% | -$25.5M-67.9% | -$24.3M | -$22.1M-87.1% |
| Income Tax | $973K | $337K | $12K+102.1% | $0+100.0% | $0-100.0% | $0-100.0% | -$564K | -$136K |
| Net Income | -$13.0M+47.5% | -$8.6M+59.8% | -$10.7M+48.0% | $8.2M+139.8% | -$24.8M-50.4% | -$21.5M-52.3% | -$20.7M | -$20.5M-87.5% |
| EPS (Basic) | -$0.29+48.2% | -$0.19+61.2% | -$0.24-101.6% | $0.18+102.1% | -$0.56+92.0% | -$0.49+92.3% | $14.61-12.9% | -$8.40-54.1% |
| EPS (Diluted) | -$0.29+48.2% | -$0.19+61.2% | -$0.24-101.6% | $0.18 | -$0.56 | -$0.49 | $14.61 | -$8.40-54.1% |
| Diluted Shares (Avg) | 45M+2.0% | 45M+1.9% | N/A | 46M | 44M | 44M | N/A | 2M+21.7% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
SEPN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $566.7M+36.5% | $569.7M+31.3% | $596.2M+30.6% | $606.7M+248.1% | $415.2M | $434.0M | $456.6M+248.9% | $174.3M |
| Current Assets | $396.2M+18.6% | $368.1M+7.5% | $411.0M+15.2% | $491.7M+268.5% | $334.1M | $342.5M | $356.8M+216.7% | $133.4M |
| Cash & Equivalents | $84.7M-55.3% | $71.6M-65.9% | $120.7M-49.3% | $320.0M+262.6% | $189.3M+44.3% | $210.0M+158.2% | $238.2M+169.2% | $88.2M-10.4% |
| Short-Term Investments | $287.7M+109.6% | $275.8M+119.0% | $270.4M+139.8% | $154.4M+265.0% | $137.3M | $126.0M | $112.7M | $42.3M |
| Accounts Receivable | $12.2M+7953.0% | $10.8M+4236.8% | $10.4M+5956.1% | $8.6M+4016.7% | $151K | $250K | $171K+13.2% | $210K |
| Long-Term Investments | $144.2M+174.0% | $174.7M+180.7% | $157.6M+125.5% | $87.2M+1149.6% | $52.6M | $62.2M | $69.9M | $7.0M |
| Total Liabilities | $180.0M+377.8% | $191.2M+466.5% | $214.3M+486.9% | $217.9M-16.7% | $37.7M | $33.8M | $36.5M-78.4% | $261.7M |
| Current Liabilities | $79.3M+424.3% | $78.2M+634.8% | $86.9M+576.6% | $75.3M+469.0% | $15.1M | $10.6M | $12.8M+85.8% | $13.2M |
| Non-Current Liabilities | $100.7M+346.6% | $113.1M+389.1% | $127.3M+438.2% | $142.6M-42.6% | $22.5M | $23.1M | $23.7M-85.4% | $248.5M |
| Total Equity | $386.7M+2.4% | $378.5M-5.4% | $381.9M-9.1% | $388.7M+544.7% | $377.6M+657.2% | $400.3M+871.3% | $420.0M+1194.6% | -$87.4M-18.4% |
| Retained Earnings | -$188.9M-14.7% | -$175.9M-25.8% | -$167.3M-41.3% | -$156.5M-60.2% | -$164.7M | -$139.8M | -$118.4M-154.2% | -$97.7M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
SEPN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$22.2M-9.3% | -$25.6M-9.8% | -$15.0M+28.5% | $168.8M+1104.0% | -$20.3M-56.2% | -$23.3M-39.7% | -$21.0M-138.2% | -$16.8M |
| Depreciation & Amortization | $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | $400K+33.3% | $400K+33.3% | $400K+100.0% | $400K+100.0% |
| Stock-Based Compensation | $5.1M+181.0% | $6.0M+305.9% | N/A | $2.5M+270.7% | $1.8M+187.6% | $1.5M+156.8% | N/A | $683K+96.8% |
| Capital Expenditures | $0-100.0% | $832K+117.8% | $65K-89.4% | $13K-97.8% | $58K-61.1% | $382K-50.0% | $612K-50.6% | $578K |
| Free Cash Flow | -$22.2M-9.0% | -$26.5M-11.5% | -$15.1M+30.2% | $168.8M+1070.5% | -$20.3M-54.9% | -$23.7M-35.8% | -$21.6M-114.9% | -$17.4M |
| Investing Cash Flow | $18.4M+2442.5% | -$23.8M-388.7% | -$185.3M-39.1% | -$38.4M-54.8% | -$786K+93.5% | -$4.9M-150.9% | -$133.2M-10653.8% | -$24.8M |
| Financing Cash Flow | $16.8M+4862.8% | $333K+404.5% | $1.0M-99.7% | $263K+119.9% | $339K | $66K | $304.2M | -$1.3M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SEPN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -62.9% | -50.1% | -66.4% | 12.2% | -24351.3% | -11831.1% | -11659.4% | -12812.5% |
| Net Margin | -48.7% | -32.6% | -44.5% | 38.0% | -20872.3% | -9806.4% | -9749.1% | -11660.8% |
| Return on Equity | -3.4%+3.2pp | -2.3%+3.1pp | -2.8%+2.1pp | 2.1% | -6.6% | -5.4% | -4.9% | N/A |
| Return on Assets | -2.3%+3.7pp | -1.5%+3.4pp | -1.8%+2.7pp | 1.4%+13.1pp | -6.0% | -5.0% | -4.5% | -11.8% |
| Current Ratio | 4.99-17.1x | 4.71-27.5x | 4.73-23.0x | 6.53-3.6x | 22.09 | 32.19 | 27.77+11.5x | 10.08 |
| Debt-to-Equity | 0.47+0.4x | 0.51+0.4x | 0.56+0.5x | 0.56 | 0.10 | 0.08 | 0.09 | N/A |
| Asset Turnover | 0.050.0x | 0.050.0x | 0.040.0x | 0.040.0x | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Margin | -82.9% | -99.8% | -62.4% | 785.3% | -17096.6% | -10833.3% | -10174.5% | -9881.8% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Septerna, Inc. SEPN | FY2025 | $46.0M | -$48.9M | N/A | $1.8B | 47/100 |
| Tyra Biosciences, Inc. TYRA | FY2025 | N/A | -$119.9M | N/A | $1.4B | — |
| Terns Pharmaceuticals, Inc. TERN | FY2025 | N/A | -$96.2M | N/A | $6.1B | — |
| AnaptysBio, Inc. ANAB | FY2025 | $234.6M | -$13.2M | -5.6% | $1.4B | 80/100 |
| Keros Therapeutics, Inc. KROS | FY2025 | $243.9M | $87.0M | 35.7% | $230.8M | 91/100 |
| Savara Inc. SVRA | FY2025 | N/A | -$118.8M | N/A | $992.4M | — |
Where Septerna, Inc. Ranks
Frequently Asked Questions
What is Septerna, Inc.'s annual revenue?
Septerna, Inc. (SEPN) reported $46.0M in total revenue for fiscal year 2025. This represents a 4174.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Septerna, Inc.'s revenue growing?
Septerna, Inc. (SEPN) revenue grew by 4174.5% year-over-year, from $1.1M to $46.0M in fiscal year 2025.
Is Septerna, Inc. profitable?
No, Septerna, Inc. (SEPN) reported a net income of -$48.9M in fiscal year 2025.
What is Septerna, Inc.'s EBITDA?
Septerna, Inc. (SEPN) had EBITDA of -$66.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Septerna, Inc.'s return on equity (ROE)?
Septerna, Inc. (SEPN) has a return on equity of -12.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Septerna, Inc.'s free cash flow?
Septerna, Inc. (SEPN) generated $109.7M in free cash flow during fiscal year 2025. This represents a 257.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Septerna, Inc.'s operating cash flow?
Septerna, Inc. (SEPN) generated $110.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Septerna, Inc.'s total assets?
Septerna, Inc. (SEPN) had $596.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Septerna, Inc.'s capital expenditures?
Septerna, Inc. (SEPN) invested $518K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Septerna, Inc. spend on research and development?
Septerna, Inc. (SEPN) invested $97.6M in research and development during fiscal year 2025.
What is Septerna, Inc.'s current ratio?
Septerna, Inc. (SEPN) had a current ratio of 4.73 as of fiscal year 2025, which is generally considered healthy.
What is Septerna, Inc.'s debt-to-equity ratio?
Septerna, Inc. (SEPN) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Septerna, Inc.'s return on assets (ROA)?
Septerna, Inc. (SEPN) had a return on assets of -8.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Septerna, Inc.'s P/E ratio?
Septerna, Inc. (SEPN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.8B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Septerna, Inc.'s price-to-sales ratio?
Septerna, Inc. (SEPN) trades at 18.1x sales, its market capitalization divided by revenue of $98.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.8B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Septerna, Inc.'s Altman Z-Score?
Septerna, Inc. (SEPN) has an Altman Z-Score of 4.97, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Septerna, Inc.'s Piotroski F-Score?
Septerna, Inc. (SEPN) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Septerna, Inc.'s earnings high quality?
Septerna, Inc. (SEPN) reported a net loss of $48.9M while generating $110.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Septerna, Inc.?
Septerna, Inc. (SEPN) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.